Troop Support procures nerve agent antidote, enhances warfighter readiness
U.S. Air Force 627th Civil Engineer Squadron engineers transport a simulated casualty after rendering tactical combat casualty care and administering an antidote treatment nerve agent autoinjector at Joint Base Lewis-McChord, Washington, Sept. 25, 2025. Exercise scenarios prepare deployers to deliver life-saving aid to both ballistic and chemical casualties under stress of enemy fire and chemical warfare agent exposure. Safeguarding warfighters’ lives in contested logistics environments, the Defense Logistics Agency Troop Support Medical supply chain strategically negotiated with medical industry partners to reopen a line of supply for Nerve Agent Antidote Autoinjectors this Dec. 2025.